Literature DB >> 15856174

Detrimental effect of sinusoidal overperfusion after liver resection and partial liver transplantation.

Daniel Palmes1, Tymoteusz B Budny, Karl-Heinz Dietl, Hermann Herbst, Udo Stratmann, Hans-Ullrich Spiegel.   

Abstract

Liver resection exposes the remaining sinusoids to an over-proportional blood flow. This mechanism may aggravate ischaemia/reperfusion damage and rejection in partial liver transplants. We studied the potential relevance of this mechanism for the pathogenesis of partial liver transplant dysfunction. Eighty-four isogeneic Lewis rats were divided into four groups: (I) sham operation; (II) partial liver resection (30% residual liver volume); (III) orthotopic transplantation of a full-size liver; (IV) transplantation of a reduced-size liver (30% transplant volume). Microcirculation was determined by intravital microscopy 90 min after surgery. Survival rates, liver function and morphology were monitored over a period of 14 days. Lowest survival rates and impaired liver function were observed after partial liver transplantation (group IV). These transplants displayed the lowest perfusion rate and an increased rate of leukocyte-endothelium interactions in the presence of a significantly increased sinusoidal blood flow velocity compared with those in groups I and III. Sinusoidal overperfusion in groups II and IV resulted in widespread endothelium lesions. Sinusoidal overperfusion seems to be a significant factor impairing liver function after liver resection. In addition to other adverse factors, such as ischaemia/reperfusion injury, it can contribute to the pathogenesis of postoperative dysfunction of partial liver transplants.

Entities:  

Mesh:

Year:  2005        PMID: 15856174     DOI: 10.1007/s00147-005-0809-9

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Extracorporeal continuous portal diversion plus temporal plasmapheresis for "small-for-size" syndrome.

Authors:  Peng Hou; Chao Chen; Yu-Liang Tu; Zi-Man Zhu; Jing-Wang Tan
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Prediction of small for size syndrome after extended hepatectomy: Tissue characterization by relaxometry, diffusion weighted magnetic resonance imaging and magnetization transfer.

Authors:  Christian Eberhardt; Moritz C Wurnig; Andrea Wirsching; Cristina Rossi; Idana Feldmane; Mickael Lesurtel; Andreas Boss
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

3.  Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT).

Authors:  Kayvan Mohkam; Michel Rayar; Jean-Philippe Adam; Fabrice Muscari; Agnès Rode; Philippe Merle; Pierre Pradat; Stéphanie Bauler; Isabelle Delfour; Laurence Chiche; Christian Ducerf; Karim Boudjema; Mickaël Lesurtel; Christophe Laurent; Jean-Yves Mabrut
Journal:  BMC Cancer       Date:  2018-08-23       Impact factor: 4.430

4.  Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma.

Authors:  Wei Peng; Xiao-Yun Zhang; Chuan Li; Tian-Fu Wen; Lv-Nan Yan; Jia-Yin Yang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  The technique of 3D reconstruction combining with biochemistry to build an equivalent formula of indocyanine green (ICG) clearance test to assess the liver reserve function.

Authors:  Jinli Zheng; Wei Xie; Yang Huang; Yunfeng Zhu; Li Jiang
Journal:  BMC Surg       Date:  2020-11-12       Impact factor: 2.102

6.  Portal Hyperperfusion after Extended Hepatectomy Does Not Induce a Hepatic Arterial Buffer Response (HABR) but Impairs Mitochondrial Redox State and Hepatocellular Oxygenation.

Authors:  Stefan Dold; Sven Richter; Otto Kollmar; Maximilian von Heesen; Claudia Scheuer; Matthias W Laschke; Brigitte Vollmar; Martin K Schilling; Michael D Menger
Journal:  PLoS One       Date:  2015-11-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.